Is Amazon an AI Stock?
With the market starting to look skittish on pure-play AI…
Buy
62
IDXX Quote, Financials, Valuation and Earnings
Last price:
$720.69
Seasonality move
:
7.13%
Day range:
$714.17 - $732.03
52-week range:
$356.14 - $769.98
Dividend yield:
0%
P/E ratio:
57.55x
P/S ratio:
14.20x
P/B ratio:
37.13x
Volume:
505.1K
Avg. volume:
634.7K
1-year change:
68%
Market cap:
$58B
Revenue:
$3.9B
EPS (TTM):
$12.61
Analysts' Opinion
-
Consensus RatingIDEXX Laboratories, Inc. has received a consensus rating of Leans Bullish. The company's average rating is a Leans Bullish based on 5 Buy ratings, 5 Hold ratings, and 1 Sell rating.
-
Price Target UpsideAccording to analysts' consensus price target of $759.00, IDEXX Laboratories, Inc. has an estimated upside of 4.56% from its current price of $725.93.
-
Price Target DownsideAccording to analysts, the lowest downside price target is $470.00 representing 35.26% downside risk from its current price of $725.93.
Fair Value
-
According to the consensus of 11 analysts, IDEXX Laboratories, Inc. has 4.56% upside to fair value with a price target of $759.00 per share.
IDXX vs. S&P 500
-
Over the past 5 trading days, IDEXX Laboratories, Inc. has underperformed the S&P 500 by -5.32% suggesting its relative strength compared to the major market average is weak at this time.
Share Buyback
-
IDEXX Laboratories, Inc. does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
IDEXX Laboratories, Inc. has grown year-over-year revenues for 43 quarters straight. In the most recent quarter IDEXX Laboratories, Inc. reported revenues of $1.1B.
Earnings Growth
-
IDEXX Laboratories, Inc. has grown year-over-year earnings for 5 quarters straight. In the most recent quarter IDEXX Laboratories, Inc. reported earnings per share of $3.40.
Enterprise value:
58.9B
EV / Invested capital:
22.01x
Price / LTM sales:
14.20x
EV / EBIT:
45.02x
EV / Revenue:
14.13x
PEG ratio (5yr expected):
2.65x
EV / Free cash flow:
62.61x
Price / Operating cash flow:
62.95x
Enterprise value / EBITDA:
40.66x
Gross Profit (TTM):
$2.6B
Return On Assets:
30.99%
Net Income Margin (TTM):
24.65%
Return On Equity:
66.88%
Return On Invested Capital:
39.29%
Operating Margin:
32.28%
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-09-30 | 2024-09-30 | 2025-09-30 | 2024-09-30 | 2025-09-30 | |
| Income Statement | ||||||
| Revenue | $3.6B | $3.8B | $4.2B | $975.5M | $1.1B | |
| Gross Profit | $2.1B | $2.3B | $2.6B | $595.5M | $685.3M | |
| Operating Income | $1.1B | $1.1B | $1.3B | $303.4M | $356.8M | |
| EBITDA | $1.2B | $1.2B | $1.4B | $337.5M | $393.4M | |
| Diluted EPS | $9.80 | $10.36 | $12.61 | $2.80 | $3.40 | |
| Period Ending | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2025-09-30 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | $883.6M | $1B | $1.3B | $1.4B | $1.4B | |
| Total Assets | $2.4B | $2.6B | $3.1B | $3.4B | $3.4B | |
| Current Liabilities | $633.8M | $1.2B | $970.2M | $1B | $1.3B | |
| Total Liabilities | $1.6B | $2.2B | $1.8B | $1.7B | $1.8B | |
| Total Equity | $755.5M | $476M | $1.3B | $1.6B | $1.6B | |
| Total Debt | $963.2M | $853.9M | $870.3M | $727.3M | $631.3M | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-09-30 | 2024-09-30 | 2025-09-30 | 2024-09-30 | 2025-09-30 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | $829.7M | $916.8M | $1.1B | $220.1M | $402.3M | |
| Cash From Investing | -$144M | -$197.7M | -$148M | -$27.4M | -$44.9M | |
| Cash From Financing | -$456.4M | -$747.1M | -$1B | -$291M | -$313.3M | |
| Free Cash Flow | $679.3M | $792.6M | $940.2M | $192M | $357.9M | |
IDXX
Sector
Market Cap
$58B
$28.4M
Price % of 52-Week High
94.28%
50.35%
Dividend Yield
0%
0%
Shareholder Yield
2.21%
-1.32%
1-Year Price Total Return
68%
-22.19%
Beta (5-Year)
1.668
0.521
Dividend yield:
0%
Annualized payout:
$0.00
Payout ratio:
--
Growth streak:
0 years
Technicals
8-day SMA
Sell
Level
$742.65
200-day SMA
Buy
Level
$556.73
Bollinger Bands (100)
Buy
Level
0 - 0
Chaikin Money Flow
Sell
Level
--
20-day SMA
Buy
Level
$716.81
Relative Strength Index (RSI14)
Buy
Level
53.70
ADX Line
Neutral
Level
0
Williams %R
Neutral
Level
-42.0605
50-day SMA
Buy
Level
$669.73
MACD (12, 26)
Buy
Level
19.90
25-day Aroon Oscillator
Buy
Level
80
On Balance Volume
Neutral
Level
--
Financial Scores
Buy
Altman Z-Score
(Annual)
Level (16.5988)
Buy
CA Score
(Annual)
Level (1.415)
Buy
Beneish M-Score
(Annual)
Level (-2.468)
Buy
Momentum Score
Level (9)
Buy
Ohlson Score
Level (-1.7887)
Buy
Piotroski F Score
(Annual)
Level (6)
Buy
Quality Ratio Score
Level (9)
Buy
Fundamental Score
Level (8)
Revenue Forecast
Earnings per Share Forecast
Company Profile
IDEXX Laboratories, Inc. engages in the development, manufacture, and distribution of products and services for the animal veterinary, livestock and poultry, dairy, and water testing markets. It operates through the following segments: Companion Animal Group (CAG), Water Quality Products (Water), Livestock, Poultry, and Dairy (LPD), and Other. The CAG segment provides diagnostic and information management-based products and services for the companion animal veterinary industry, including in-clinic diagnostic solutions, outside reference laboratory services, and veterinary software and services. The Water segment offers innovative testing solutions for easy, rapid, and accurate detection and quantification of various microbiological parameters in water. The LPD segment develops diagnostic tests, services, and related instrumentation that are used to manage the health status of livestock and poultry, to improve producer efficiency, and to ensure the quality and safety of milk and food. The Other segment is composed of products for the human point-of-care medical diagnostics market with its out-licensing arrangements. The company was founded by David Evans Shaw on December 19, 1983, and is headquartered in Westbrook, ME.
Stock Forecast FAQ
In the current month, IDXX has received 5 Buy ratings 5 Hold ratings, and 1 Sell ratings. The IDXX average analyst price target in the past 3 months is $759.00.
-
Where Will IDEXX Laboratories, Inc. Stock Be In 1 Year?
According to analysts, the consensus estimate is that IDEXX Laboratories, Inc. share price will rise to $759.00 per share over the next 12 months.
-
What Do Analysts Say About IDEXX Laboratories, Inc.?
Analysts are divided on their view about IDEXX Laboratories, Inc. share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that IDEXX Laboratories, Inc. is a Sell and believe this share price will drop from its current level to $470.00.
-
What Is IDEXX Laboratories, Inc.'s Price Target?
The price target for IDEXX Laboratories, Inc. over the next 1-year time period is forecast to be $759.00 according to 11 Wall Street analysts, 5 of them rate the stock a Buy, 1 rates the stock a Sell, and 5 analysts rate the stock a Hold.
-
Is IDXX A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for IDEXX Laboratories, Inc. is a Leans Bullish. 5 of 11 analysts rate the stock a Leans Bullish at this time.
-
How Can I Buy Shares Of IDXX?
You can purchase shares of IDEXX Laboratories, Inc. via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase IDEXX Laboratories, Inc. shares.
-
What Is The IDEXX Laboratories, Inc. Share Price Today?
IDEXX Laboratories, Inc. was last trading at $720.69 per share. This represents the most recent stock quote for IDEXX Laboratories, Inc.. Yesterday, IDEXX Laboratories, Inc. closed at $725.93 per share.
-
How To Buy IDEXX Laboratories, Inc. Stock Online?
In order to purchase IDEXX Laboratories, Inc. stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
Related Companies
Get IDXX Stock Alert
Signup to receive the latest stock alerts
Financial Ratios
IDXX
Sector
P/E ratio
57.55x
23.66x
PEG ratio
2.65x
-0.01x
P/B ratio
37.13x
1.84x
Price / LTM sales
14.20x
1.60x
Growth Metrics
IDXX
Sector
Revenue growth
13.3%
4.85%
Earnings growth
21.42%
11.15%
Revenue (5-year growth)
10.12%
6.45%
Earnings forecast
$3.15
-$0.20
Profitability
IDXX
Sector
Profitability FY 2024
$2.4B
$3.6M
Return on invested capital
39.29%
-30.98%
Return on assets
30.99%
-27.62%
Return on equity
66.88%
-36.69%
Earnings Date
Last Earnings Date
Nov
3
Next Earnings Date
Feb
3
Estimated Next Earnings Date
Feb
2
Balance Sheet
IDXX
Sector
Total cash
$208.2M
$27.2M
Short term investments
--
$25.7M
Total assets
$3.3B
$79.9M
Long term debt
$631.3M
$4.1M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Google Vs NVIDIA Stock: Which Is Best?
Alphabet (NASDAQ:GOOGL) and NVIDIA (NASDAQ:NVIDIA) are two of the market’s…
How High Could NVIDIA Stock Go?
NVIDIA (NASDAQ:NVDA) has been one of the best stocks to…
Stock Ideas
Buy
51
Is NVDA Stock a Buy?
Market Cap: $4.4T
P/E Ratio: 61x
Buy
61
Is AAPL Stock a Buy?
Market Cap: $4.1T
P/E Ratio: 38x
Buy
69
Is GOOG Stock a Buy?
Market Cap: $3.9T
P/E Ratio: 40x
Alerts
Sell
47
PSTG alert for Dec 4
Pure Storage, Inc. [PSTG] is up 5.05% over the past day.
Sell
41
SMX alert for Dec 4
SMX (Security Matters) Plc [SMX] is up 154.74% over the past day.
Sell
43
HY alert for Dec 4
Hyster-Yale, Inc. [HY] is up 1.92% over the past day.
THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS
Show me the best stock
